Moving toward improved cell replacement therapy for Parkinson's disease

Parkinson's disease, which affects millions worldwide, results from neuron loss. Transplantation of fetal tissue to restore this loss has shown promise, but ethical concerns over acquiring this tissue limit its use.

In a June 17 study in the Journal of Clinical Investigation, Vania Broccoli and others at the San Raffaele Scientific Institute converted fibroblasts into neurons and engrafted them into the brains of rodents with parkinsonism.

The cells improved motor function, but not as well as transplanted rat fetal tissues. The authors then used a technology that allows the neurons to express engineered proteins, which respond to a specific drug to regulate neuronal activity. These neurons restored almost as well as rat .

An accompanying article discusses how this study potentially provides a promising source of replacement neurons in Parkinson's disease.

More information: Remote control of induced dopaminergic neurons in parkinsonian rats, Journal of Clinical Investigation, DOI: 10.1172/JCI74664

add to favorites email to friend print save as pdf

Related Stories

Is Parkinson's an autoimmune disease?

Apr 17, 2014

The cause of neuronal death in Parkinson's disease is still unknown, but a new study proposes that neurons may be mistaken for foreign invaders and killed by the person's own immune system, similar to the ...

Recommended for you

How coffee protects against Parkinson's

Jul 11, 2014

A specific genetic variation discovered by researchers at Linköping University in Sweden protects against Parkinson's Disease – especially for those who drink a lot of coffee.

User comments